Stay updated on Neratinib vs Lapatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib vs Lapatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib vs Lapatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T05:50:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T00:22:31.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding 3 more interventions/treatments and indicating that the study now has 1 location.
    Difference
    0.5%
    Check dated 2024-07-23T14:58:07.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:14:44.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T14:31:12.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:09:24.000Z thumbnail image

Stay in the know with updates to Neratinib vs Lapatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.